Studies on the mechanisms of action of hormones have been largely restricted to attempts at tracking the tissue response to a hormone back to its site of action. Underlying these studies has been the assumption that at this site one would find the hormone interacting with some receptor in the target tissue (e.g., Szego, 1957; Bush, 1964; Hechter and Halkerston, 1964) . These assumptions have included the idea that the distribution of the receptor determines tissue specificity and that the nature of the hormone-receptor complex controls the character of the tissue's response. Despite their theoretical importance, these beliefs have had little experimental basis.
Jensen and co-workers (1962) initiated a new attack on this problem in a series of elegant experiments which gave support to the receptor hypothesis. Using tritium-labeled estradiol, they showed a preferential binding of estrogens in the uterus and vagina but not in nontarget tissues. These studies were extended by Noteboom and Gorski (1965) , who reported that the estrogen receptor is stereospecific and probably a protein. Subcellular fractionation of the rat uterus indi-cated that approximately 50 per cent of the receptor was in a heavy nuclear-myofibrillar fraction and 30 per cent in the soluble (105,000 X g supernatant) fraction. Isolation of the estrogen receptor from soluble uterine fractions by molecular sieving chromatography has been tried unsuccessfully by Talwar et al. (1964) and by Noteboom (1965) .
We now report the isolation and the preliminary characterization of a macromolecular component which has the attributes of the specific receptor for estrogens.
Methods and Materials.-Immature Holtzman rats (20-23 days old) were injected intraperitoneally with various amounts of chromatographically pure 6,7-H3-estradiol-17f3 (140 or 150 ,c/,ug, New England Nuclear) in 0.5 ml of 0.9 per cent NaCl-2 per cent ethanol. In some experiments, chromatographically pure estradiol-17a, corticosterone, testosterone, or diethylstilbestrol was injected in the same manner. The rats were decapitated 20 min to 4 hr after the injection. The uteri were removed immediately and placed on ice. Groups of five uteri were homogenized together in 0.5 ml of buffer [0.01 M Tris (tris[hydroxymethyllaminomethane) and 0.0015 M EDTA (ethylenediaminetetraacetic acid), pH 7.4, or 0.04 M Tris-0.004 M MgCl2-0.1 M KCI, pH 7.4]. The homogenates were centrifuged at 105,000 X g for 1.5 hr to remove particulate material. Tris-EDTA was found to be more suitable for removing particulate material. The soluble supernatant fractions (0.2 ml) were layered on 4.4-ml gradients of 5-20 per cent sucrose in 0.01 M Tris buffer, pH 7.4, and were centrifuged for 9-12 hr at 39,000 rpm in a Spinco model L using a SW-39 rotor (method of Martin and Ames, 1961) . These operations were done at 0-40C. The tubes were pierced and the eluate was run through a Beckman DB flow cell to obtain optical density readings at 280 mis. The eluate was collected in a fraction collector (0.2 + 0.01 ml/fraction), 3 ml of ethanol and 10 ml scintillation (1961) , using beef liver catalase as a standard.
Results.-The sedimentation analysis of the soluble uterine fraction from animals injected 3.5 hr earlier with various doses of H3-estradiol-17f showed a dominant peak of radioactivity sedimenting at approximately 9.5S (Fig. 1) . With the biologically effective, lower doses, only the 9.5S region was labeled ( Fig. 1A and B) . This region is well separated from the major portion of material absorbing UV at 280 m/i. With doses greater than 0.1 Ag per rat, the 9.5S peak increased relatively little, but estradiol also appeared as a broad peak in the less dense, 3-6S region of the gradient (Fig. 1C and D) . It seems unlikely that the binding in this region is physiologically significant, because it is not produced with lower, biologically active doses. Noteboom and Gorski (1965) had found that if more than 0.01-0.02 ,ug of hormone were injected, the excess was lost from the uterus within a few hours. It appears, however, that in the 3.5 hr following injection, all of the excess hormone had not been removed by the circulation and some hormone appears in the 3-6S region. Serum albumin, the major carrier of estrogens in the blood (Westphal, 1961) , migrates in this region and may be the protein to which excess hormone is bound. It is also possible that if present in excess, estradiol, which is only slightly soluble in aqueous solutions, is readily absorbed by hydrophobic regions of protein and lipid material.
From the data plotted in Figure ID , it was determined that the 9.5S component bound approximately 4.4 X 10-8 Mmoles of estradiol per uterus, a value which is in close agreement with the estrogen level estimated by Noteboom and Gorski (1965) . (The saturation level was estimated for the nuclear-myofibrillar fraction to be 5.34 X 10-1 to 8.01 X 10-8,moles of estradiol, or approximately 10 X 10-8 to 16 X 10-8 Mmoles per whole uterus. The soluble fraction would then contain approximately 3 X 10-8 to 5 X 10-8,moles/uterus.)
If the uterine component under study were the receptor, binding should be evident early after administration of the hormone, and no later than the first known estrogen responses. When 0.01 ,ug of estradiol was given, maximal binding to the 9.5S component occurred within 20 min, the earliest time studied. No qualitative change in the patterns could be seen at later time periods. The sedimentation patterns 1 hr after hormone injection resemble those seen after 3.5 hr, but more hormone is present (Fig. 2) . (Note that in this and the following experiments the gradients were centrifuged at 30C, whereas in Figs. 1 and 4, centrifugation was at approximately 100C. The lower temperature accounts for the upward shift of the pattern.) When 0.13 1Ag of hormone was given, the dominant peak of radioactivity was in the 9.5S region. With twice the dose, there was binding to both the 9.5S and 4-5S regions, and free estradiol appeared at the top of the gradient. the 9.5S component contained over twice as much hormone ('-.'1 X 10-7 Amoles/ uterus) as it had at 3.5 hr.
If the 9.5S component were the physiological receptor, it should also display tissue specificity. To test this prediction, we studied rat intestine and serum 1 hr after injection of estradiol. The serum and the soluble fraction from intestine did contain a small amount of estradiol, but there was no binding that corresponded to the 9.5S peak in the uterus (Fig. 3) . Estradiol appeared to be unbound in the gradient prepared from intestine; in the serum the hormone was bound to material sedimenting between the 4 and 8S regions. After 1 hr, the ratio of hormone to protein was much lower in these tissues than in the uterus. Jensen and Jacobson's report (1962) that nontarget organs were depleted of estradiol within 2 hr provides additional support for the specificity of binding in the uterus.
It was equally important to determine the specificity of binding for compounds with estrogenic activity. The ability of various substances to compete with the binding of H3-estradiol-17$ was tested by injecting test compounds together with 0.02 ,ug of H3-estradiol-17f3. The rats were killed 2 or 4 hr later, and the soluble uterine fraction was analyzed by sucrose gradient centrifugation. One jig of corticosterone or testosterone had no effect on the binding of estradiol-17#; however, ceptor molecule. It binds to estrogens but not to nonestrogenic steroids. Maximal binding occurs within minutes, a time necessary to precede the biochemical events that make up the hormone response. The hormone in the soluble fraction is almost completely bound to this macromolecular component when one administers low levels of hormone which produce typical, physiological responses. The binding entity was not detected in serum or in the small intestine, although the latter tissue is rather similar in composition to the uterus. Its sensitivity to proteolytic enzymes, its specificity in binding, and its size make it probable that the receptor molecule is a large protein. Although the 9.5S component migrated as a single peak, there was some variation in the symmetry of the peak, indicating the need for further characterization and purification. The molecule may have other components such as lipid or carbohydrate, or it may be an aggregated structure. The latter possibility is especially appealing, as the hormone-receptor interaction could well involve an allosteric protein. The binding of specific effector substances to certain enzymes activates or inhibits them, apparently by altering the interaction or conformation of their subunits (Monod et al., 1965) . It now may be possible to test whether the binding of estrogen alters the physical properties of the receptor. However, the extremely small amount of the receptor molecule hampers these investigations. Using an approximate molecular weight of 200,000 [estimated from the sedimentation, assuming that the molecule is a spherical protein (see Martin and Ames, 1961) ], the highest level of estradiol which was measured ('1 X 10-7 ;moles per uterus), and assuming one binding site per receptor molecule, one can calculate the maximal amount of soluble receptor which contained bound estradiol in our experiments to be 1.4-2 X 10-1 1Ag per uterus. It is not known how close this is to the total amount of receptor in the uterus, or how many binding sites per receptor, but this estimation suggests that the amount of material available is very small. The highest levels of bound estradiol observed in these experiments are above that level which, upon extrapolation from the studies of Noteboom and Gorski (1965) , should saturate the uterine soluble fraction (4); however, this saturation value is based on in vivo studies of the nuclearmyofibrillar fraction, and may not be applicable to binding in the soluble fraction.
When speaking in terms of actual binding levels and saturation, one must relate these data to what is known about the binding of small molecules to macromolecules.
When estradiol was injected in amounts less than 0.1 ,ug, the hormone was stoichiometrically bound to the 9.5S component, which indicates that the estradiol concentration may be quite a bit lower than the concentration of receptor. Only when estradiol was administered at higher levels and for shorter time periods ( Fig. 1C  and D; Fig. 2 ) was there evidence of an equilibrium between bound and unbound hormone. The in vivo system which has been used in these studies is not well suited for a complete study of binding kinetics. Many complications arise when one must consider biological variables, such as the continuous variation of hormone concentration, the contributing effects of carrier proteins in the blood, and the possible compartmentation effects within the tissue. In vitro studies are now in progress which may allow a more quantitative analysis of the binding kinetics.
No information is known as to the relationship between the soluble receptor and the particulate-bound receptor described by Noteboom and Gorski. About 60-70 per cent of the estradiol bound to the uterus is present in the particulate fraction. At present we do not know whether the particulate receptor is a different state of the same molecule found in the soluble phase, or is quite dissimilar, or if they even originate from the same type of cells. Available evidence is compatible with a situation in which estrogen receptors in both phases are basically the same, but are either separated artificially by the extraction procedure, or exist in a close physiologic relationship in both phases.
Summary.-A component of the 105,000 X g supernatant fraction of the rat uterus has been isolated which has properties of a specific receptor for estrogens. The "receptor" is a macromolecule having a sedimentation coefficient of approximately 9.5S. This receptor has, so far, been observed only in the uterus, and not in the small intestine or blood serum. When physiological amounts of estrogen are administered, binding of estrogen is exclusively with the 9.5S component, but at higher amounts some estrogen is associated with other components of the soluble fraction. The binding to the 9.5S component is antagonized by diethylstilbestrol, but not by the nonestrogenic steroids, testosterone and corticosterone. Binding to the receptor is abolished by treatment with proteolytic enzymes, but not by nucleases. Its enzyme sensitivity, its large size, and its binding specificity suggest that this component is a protein and may be of major importance in the mechanism of estrogen action. April 25, 1966 Increases in at least three deoxyribonuclease activities occur in HeLa cells after infection with poxvirus. These nucleases can be conveniently described by their substrate preference and pH of maximal activity as (1) an alkaline DNase (doublestrand DNA),1 (2) an acid DNase (single-strand DNA),2 and (3) a DNase acting maximally at pH 7.8 on single-strand DNA.3 We shall refer to the latter as neutral DNase. The first two DNases have been tentatively characterized as exonucleases.4 Since the increase in their activities postinfection can be inhibited by puromycin, it was suggested that the increases are probably due to virusinduced synthesis of the enzymes rather than simple activation.' 2 In contrast to the stability of the messenger for virus-induced thymidine kinase synthesis,' the messengers for the synthesis of the first two DNases in question are comparatively unstable.2 We have examined the possibility that the regulation of the synthesis of the DNases might differ in character from that described for induced thymidine kinase synthesis which appears to involve regulation of messenger translation.' The regulation of the induced alkaline and acid DNases have been compared with that of thymidine kinase. We present evidence that different control mechanisms exist for different poxvirus-induced enzymes.
Materials and Methods.-Virus strains: The virus strains used were the Utrecht strain of rabbitpox, the Brighton strain of cowpox, a red-pock isolate of the Connaught Laboratories' strain of poxvirus, and the WR strain of rabbitpox. Their preparation, titration, and biological properties have been described.6. 7 Virus was purified by centrifugation through sucrose. '7 Cultivation and infection of cells: The cultivation of HeLa S3 cells in suspension and the procedure used to infect them with virus have been described.8
Preparation of cell extracts and assay of enzymes: Cells were harvested by centrifugation at various times after infection, washed once in 0.1 M Tris-HCl buffer pH 7.8, and then allowed to swell in hypotonic medium before disruption in a Dounce homogenizer.9 After removal of nuclei by centrifugation at 600 X g for 10 min, the cytoplasmic fraction was used either directly or further centrifuged (10,000 g for 30 min) before assay of enzymes. The assays for deoxyribonucleases and thymidine kinase were those described in detail elsewhere. '. 2, 8 The substrate for DNase assays was tritiated DNA prepared by Marmur's method's from E. coli T-grown to a limit in tris-glucose medium containing 1 me thymine-H3 per liter. Single-strand DNA for the acid DNase assay was prepared by heating DNA-H3 (70 ;g per ml in 0.01 M Tris-HCl pH 7.2) at 100'C for 10 min prior to rapid chilling to 0°.
Polysome preparation: Ribosomes were extracted from normal or infected cells and fractionated on 5-20% sucrose gradients.'0 Pulse-labeling studies using uridine-C'4 were conducted by using methods described by Becker and Joklik."1 Under the conditions of the experiment in which cells were subjected to uridine-C'4 pulses of no longer than 15 min, there is no significant
